Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve the unaudited standalone ....
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova has informed the stock exchanges that its Board of Directors will meet on Tuesday, July 29, 2025. The main item on the agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). This is a standard advance intimation required by SEBI listing rules before quarterly results are announced. No financial numbers or business details have been shared yet — investors will need to wait for the actual results on or after July 29. The filing was signed by Company Secretary Naresh Kapoor on July 23, 2025.
This is a routine procedural filing and has no direct impact on the stock. Investors should watch for the actual Q1 FY26 results on July 29 for insights into revenue, profitability, and segment performance.